InvestorsHub Logo
icon url

mrpatinmn

12/21/13 2:55 PM

#10315 RE: mackwheaton #10314

You guys know me well enough that when I say this you won't think I'm soft bashing; so here is my take on ONCS, which at one time I held a pantload of shares. On the plus side for both, it is becoming clearer all the time that EP is a big part of the synthetic DNA success. My own personal experience with INO and ONCS in the earlier times, was that just when they seemed to get rolling, along would come dilution in some form or other, and knock back the pps 20%. It's still a possibility with ONCS, and I highly doubt it with INO. I do think it's realistic for ONCS to be a four bagger next year, and INO a 2 to 3 bagger. Their market caps are going to really launch on good results. Based on what we know, they're both great bets for 2014. GLTlongs.